Published in J Virol on November 16, 2011
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature (2015) 3.46
Response to "Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics". Neuro Oncol (2014) 2.08
Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis (2013) 1.80
Genetic analysis of cytomegalovirus in malignant gliomas. J Virol (2012) 1.19
Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clin Cancer Res (2014) 1.05
Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One (2013) 1.04
Is human cytomegalovirus a target in cancer therapy? Oncotarget (2011) 1.04
Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Res (2015) 0.90
Human cytomegalovirus pUL79 is an elongation factor of RNA polymerase II for viral gene transcription. PLoS Pathog (2014) 0.86
Control the host cell cycle: viral regulation of the anaphase-promoting complex. J Virol (2013) 0.84
Absence of human cytomegalovirus infection in childhood brain tumors. Am J Cancer Res (2015) 0.83
Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells. PLoS One (2013) 0.82
Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell Death Differ (2015) 0.82
Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein. Sci Adv (2015) 0.81
RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions. J Virol (2012) 0.80
The oncomodulatory role of human cytomegalovirus in colorectal cancer: implications for clinical trials. Front Oncol (2014) 0.80
The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replication. J Virol (2015) 0.80
Selection of a highly invasive neuroblastoma cell population through long-term human cytomegalovirus infection. Oncogenesis (2012) 0.80
Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. Oncoimmunology (2015) 0.79
Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme. Front Oncol (2014) 0.79
Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle. J Virol (2013) 0.79
Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97. J Biol Chem (2015) 0.78
Human cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells. Oncol Lett (2014) 0.78
Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS One (2014) 0.78
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options. World J Exp Med (2015) 0.78
Vaccine-based immunotherapeutic approaches to gliomas and beyond. Nat Rev Neurol (2017) 0.77
A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication. J Virol (2013) 0.77
No evidence of association between human cytomegalovirus infection and papillary thyroid cancer. World J Surg Oncol (2014) 0.77
Human cytomegalovirus gene expression in long-term infected glioma stem cells. PLoS One (2014) 0.77
Structural Diversity in Conserved Regions Like the DRY-Motif among Viral 7TM Receptors-A Consequence of Evolutionary Pressure? Adv Virol (2012) 0.77
Human cytomegalovirus-encoded US28 may act as a tumor promoter in colorectal cancer. World J Gastroenterol (2016) 0.77
A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association. Acta Neuropathol Commun (2016) 0.76
Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma. Oncol Lett (2015) 0.76
Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery. Oncoimmunology (2015) 0.76
Modeling cytomegalovirus infection in mouse tumor models. Front Oncol (2015) 0.76
Prioritization schema for immunotherapy clinical trials in glioblastoma. Oncoimmunology (2016) 0.76
Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection. J Virol (2016) 0.76
Modulation of homology-directed repair in T98G glioblastoma cells due to interactions between wildtype p53, Rad51 and HCMV IE1-72. Viruses (2014) 0.75
Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls. Infect Agent Cancer (2016) 0.75
Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins. J Biol Chem (2017) 0.75
Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience. Mol Clin Oncol (2015) 0.75
Metagenomics: A new horizon in cancer research. Meta Gene (2015) 0.75
Immunotherapy in glioblastoma: emerging options in precision medicine. CNS Oncol (2016) 0.75
Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades. PLoS One (2016) 0.75
Increased infiltration and tolerised antigen-specific CD8(+) TEM cells in tumor but not peripheral blood have no impact on survival of HCMV(+) glioblastoma patients. Oncoimmunology (2017) 0.75
Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes. mSphere (2017) 0.75
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. Clin Cancer Res (2017) 0.75
Phosphorylation of transcriptional regulators in the retinoblastoma protein pathway by UL97, the viral cyclin-dependent kinase encoded by human cytomegalovirus. Virology (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res (2002) 4.58
Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene (2004) 4.29
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol (2007) 2.99
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Pathway analysis of coronary atherosclerosis. Physiol Genomics (2005) 2.59
Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol (2008) 2.52
The molecular and genetic basis of neurological tumours. Nat Rev Cancer (2002) 2.41
Epidemiology of brain tumors. Methods Mol Biol (2009) 2.35
Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res (2011) 2.15
Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol (2008) 1.94
Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst (2009) 1.92
Lack of association of herpesviruses with brain tumors. J Neurovirol (2006) 1.88
Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A (1997) 1.85
Is HCMV a tumor promoter? Virus Res (2010) 1.81
Cytomegalovirus immune evasion. Curr Top Microbiol Immunol (2008) 1.80
Lymphomas differ in their dependence on Epstein-Barr virus. Blood (2010) 1.74
HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal (2010) 1.72
HCMV microinfections in inflammatory diseases and cancer. J Clin Virol (2007) 1.52
The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia (2009) 1.49
Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog (2011) 1.45
Lack of association of cytomegalovirus with human brain tumors. Mod Pathol (2005) 1.40
Dynamics of T cell memory in human cytomegalovirus infection. Med Microbiol Immunol (2008) 1.32
The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol (2010) 1.28
Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol (2008) 1.27
Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer (2005) 1.24
Specific chromosome 1 breaks induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2000) 1.21
Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol (2011) 1.17
Inhibition of programmed cell death by cytomegaloviruses. Virus Res (2010) 1.12
Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div (2009) 1.02
The role of cytomegalovirus in angiogenesis. Virus Res (2010) 0.99
Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim Biophys Acta (2011) 0.96
Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels. J Mol Diagn (2005) 0.93
Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol (2009) 0.92
Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. J Virol (2002) 0.89
Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication. MBio (2011) 0.87
HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase. Herpesviridae (2010) 0.85
Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay. Semin Oncol (2009) 0.83
Evidence that herpes simplex virus DNA derived from quiescently infected cells in vitro, and latently infected cells in vivo, is physically damaged. J Neurovirol (2010) 0.81
Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2010) 3.05
Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys (2007) 2.35
Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol (2010) 2.12
Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol (2012) 2.02
Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science (2008) 1.99
Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization. Oncogene (2004) 1.77
Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol (2007) 1.60
Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology (2007) 1.48
Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells. J Virol (2010) 1.29
Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano Lett (2007) 1.28
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One (2008) 1.26
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia (2012) 1.22
Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration. Biomicrofluidics (2011) 1.21
Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng (2006) 1.19
Extraction of a weak climatic signal by an ecosystem. Nature (2002) 1.19
Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice. PLoS One (2011) 1.15
Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc Natl Acad Sci U S A (2009) 1.14
Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases. PLoS Pathog (2010) 1.10
Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev (2007) 1.10
The cancer stem cell paradigm: a new understanding of tumor development and treatment. Expert Opin Ther Targets (2010) 1.09
Current practices of driving restriction implementation for patients with brain tumors. J Neurooncol (2010) 1.07
Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits. Tissue Eng (2007) 1.07
Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival. Clin Cancer Res (2012) 1.03
Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div (2009) 1.02
Developmental signaling pathways in brain tumor-derived stem-like cells. Dev Dyn (2007) 1.02
BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc Natl Acad Sci U S A (2012) 1.01
Increased angiogenesis and angiogenic gene expression in carotid artery plaques from symptomatic stroke patients. Neurosurgery (2006) 1.00
Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virol (2008) 0.98
Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae (2011) 0.98
Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim Biophys Acta (2011) 0.96
Tale of a tegument transactivator: the past, present and future of human CMV pp71. Future Virol (2012) 0.94
T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice. J Exp Med (2014) 0.93
microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models. PLoS One (2013) 0.92
Human embryonic stem cell lines model experimental human cytomegalovirus latency. MBio (2013) 0.92
Pediatric surgical neuro-oncology: current best care practices and strategies. J Neurooncol (2004) 0.92
Autologous stem cell regeneration in craniosynostosis. Bone (2007) 0.91
WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration. Mol Cancer (2014) 0.91
Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J Virol (2009) 0.90
Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations. J Virol (2013) 0.89
Upper cervical intramedullary spinal metastasis of ovarian carcinoma: a case report and review of the literature. J Med Case Rep (2011) 0.88
Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection. Neurosurgery (2015) 0.87
Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication. MBio (2011) 0.87
Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells. Cell Physiol Biochem (2012) 0.87
Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J Virol (2013) 0.85
Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET. Eur J Nucl Med Mol Imaging (2002) 0.85
Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine. World Neurosurg (2011) 0.85
Aspergillus infection of the orbital apex masquerading as Tolosa-Hunt syndrome. Arch Ophthalmol (2007) 0.85
Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant. J Virol (2010) 0.84
Evaluation of cancer stem cell migration using compartmentalizing microfluidic devices and live cell imaging. J Vis Exp (2011) 0.84
Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. J Endocrinol (2006) 0.84
Association of functional magnetic resonance imaging indices with postoperative language outcomes in patients with primary brain tumors. Neurosurg Focus (2013) 0.84
Nuclear localization of tegument-delivered pp71 in human cytomegalovirus-infected cells is facilitated by one or more factors present in terminally differentiated fibroblasts. J Virol (2010) 0.84
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation. Methods (2011) 0.83
Tethering tracts in spina bifida occulta: revisiting an established nomenclature. J Neurosurg Spine (2007) 0.82
Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease. Am J Hematol (2002) 0.82
Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency. J Virol (2013) 0.82
Calorie restriction attenuates astrogliosis but not amyloid plaque load in aged rhesus macaques: a preliminary quantitative imaging study. Brain Res (2013) 0.82
Symptomatic hyperprolactinemia from an ectopic pituitary adenoma located in the clivus. Endocr Pract (2009) 0.81
Growing mammary choristoma masquerading as a lumbosacral lipomyelomeningocele in a pubertal girl. J Neurosurg Pediatr (2011) 0.79
Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle. J Virol (2013) 0.79
Tenosynovial giant cell tumor of the posterior arch of C1. Skeletal Radiol (2008) 0.78
Microsurgical anatomy of the dorsal thoracic rootlets and dorsal root entry zones. Acta Neurochir (Wien) (2012) 0.78
Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Mol Pharm (2016) 0.78
Ion transporters in brain tumors. Curr Med Chem (2015) 0.77
Incidental findings on brain MRI. N Engl J Med (2008) 0.77
Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery. J Neurooncol (2013) 0.77
Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells. J Neurosurg (2015) 0.77
Morphologic studies of the placenta and autopsy findings in neonatal-onset glutaric acidemia type II. Pediatr Dev Pathol (2002) 0.76
Detection of Human Brain Tumor Infiltration With Quantitative Stimulated Raman Scattering Microscopy. Neurosurgery (2016) 0.76
Spinal intramedullary cysticercosis of the conus medullaris. WMJ (2008) 0.76
Friedreich's ataxia associated with mitochondrial myopathy: clinicopathologic report. J Child Neurol (2002) 0.76
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Neurosurgery (2014) 0.76
CLARITY--a clearer view of the brain. Neurosurgery (2013) 0.75
Chronic rhinosinusitis with nasal polyps: a proteomic analysis. Ann Otol Rhinol Laryngol (2011) 0.75
Oncolytic Herpes Simplex Virus Glioblastoma Therapy is Potentiated by Tumor Necrosis Factor-α Inhibition. Neurosurgery (2015) 0.75
Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target. Neurosurgery (2015) 0.75
Turning everything into brain? Neurosurgery (2010) 0.75
The role of secondary motor and language cortices in morbidity and mortality: a retrospective functional MRI study of surgical planning for patients with intracranial tumors. Neurosurg Focus (2013) 0.75
Clinton Woolsey: functional brain mapping pioneer. J Neurosurg (2014) 0.75
"Inhibiting the Inhibitors" to Support Axonal Regeneration. Neurosurgery (2016) 0.75
Detecting brain tumor with Raman scattering microscopy. Neurosurgery (2014) 0.75
New Molecular Insights and Potential Therapies for Diffuse Intrinsic Pontine Glioma. Neurosurgery (2015) 0.75
What is the optimal venous thromboembolism prophylaxis for gynecological oncology patients with CNS metastases? Gynecol Oncol (2011) 0.75
Giant prolactinoma. Endocr Pract (2009) 0.75
Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol (2017) 0.75
The University of Wisconsin department of neurological surgery. Neurosurgery (2010) 0.75